No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Dermatologic Agents / adverse effects*
-
Drug Substitution
-
Eosinophilia / chemically induced*
-
Eosinophilia / diagnosis
-
Humans
-
Infliximab / therapeutic use
-
Interleukin-17 / antagonists & inhibitors*
-
Interleukin-17 / immunology
-
Male
-
Pleural Effusion / chemically induced*
-
Pleural Effusion / diagnosis
-
Psoriasis / diagnosis
-
Psoriasis / drug therapy*
-
Psoriasis / immunology
-
Receptors, Interleukin-17 / antagonists & inhibitors*
-
Receptors, Interleukin-17 / immunology
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Humanized
-
Dermatologic Agents
-
IL17A protein, human
-
IL17RA protein, human
-
Interleukin-17
-
Receptors, Interleukin-17
-
brodalumab
-
Infliximab
-
secukinumab